A quadruped study on chitosan microspheres containing atorvastatin calcium: Preparation, characterization, quantification and in-vivo application

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 9, 2010, Pages 1161-1167

  Eroglu, Hakan ^a   Nemutlu, Emirhan ^a   Turkoglu, Omer Faruk ^b   Nacar, Osman ^c   Bodur, Ebru ^a   Sargon, Mustafa Fevzi ^a   Beskonakli, Etem ^b   Oner, Levent ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Ankara Numune Research and Education Hospital   (Turkey)

Author keywords

Atorvastatin; Chitosan; Microsphere; Quantification; Spinal cord injury

Indexed keywords

ATORVASTATIN; CHITOSAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICROSPHERE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; IN VIVO STUDY; LAMINECTOMY; LIPID PEROXIDATION; MICROENCAPSULATION; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHITOSAN; HEPTANOIC ACIDS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPID PEROXIDATION; MICROSPHERES; NEUROPROTECTIVE AGENTS; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TUMOR NECROSIS FACTOR-ALPHA; WOUNDS AND INJURIES;

EID: 77956312910     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.1161     Document Type: Article

References (46)

1. Ducker T. B., Kindt G. W., Kempf L. G., J. Neurosurg., 35, 700-708 (1971).
2. Pahan K., Sheikh F. G., Namboodiri A. M., Singh I., J. Clin. Invest., 100, 2671-2679 (1997).
3. Stanislaus R., Pahan K., Singh A. K., Singh I., Neurosci. Lett., 269, 71-74 (1999).
4. Vollmer T., Key L., Durkalski V., Tyor W., Corboy J., Markovic-Plese S., Preiningerova J., Rizzo M., Singh I., Lancet, 363, 1607-1608 (2004).
5. Paintlia A. S., Paintlia M. K., Khan M., Vollmer T., Singh A. K., Singh I., FASEB J., 19, 1407-1421 (2005).
6. DeKosky S. T., Am. J. Med., 118 (Suppl. 12A), 48-53 (2005).
7. Ringheim G. E., Szczepanik A. M., Curr. Pharm. Des., 12, 719-738 (2006).
8. Hess D. C., Demchuk A. M., Brass L. M., Yatsu F. M., Neurology, 54, 790-796 (2000).
9. Vaughan C. J., Delanty N., Basson C. T., CNS Drugs, 15, 589-596 (2001).
10. Moonis M., Kane K., Schwiderski U., Sandage B. W., Fisher M., Stroke, 36, 1298-1300 (2005).
11. Endres M., Laufs U., Liao J. K., Moskowitz M. A., Trends Neurosci., 27, 283-289 (2004).
12. Pannu R., Barbosa E., Singh A. K., Singh I., J. Neurosci. Res., 79, 340-350 (2005).
13. Pannu R., Christie D. K., Barbosa E., Singh I., Singh A. K., J. Neurochem., 101, 182-200 (2007).
14. Amarenco P., Neurology, 57 (Suppl. 2), S35-S44 (2001).
15. Vaughan C. J., Delanty N., Stroke, 30, 1969-1973 (1999).
16. Hebert P. R., Gaziano J. M., Hennekens C. H., Arch. Intern. Med., 155, 50-55 (1995).
17. Bosel J., Gandor F., Harms C., Synowitz M., Harms U., Djoufack P. C., Megow D., Dirnagl U., Hortnagl H., Fink K. B., Endres M., J. Neurochem., 92, 1386-1398 (2005).
18. Romoren K., Thu B. J., Evensen O., J. Controlled Release, 85, 215-225 (2002).
19. Rao S. B., Sharma C. P., J. Biomed. Mater. Res., 34, 21-28 (1997).
20. Hirano S., Hirochi K., Hayashi K., Mikami T., Tachibana H., "Cosmetic and Pharmaceutical Applications of Polymers," ed. by Gebelin C., Cheng T. C., Yang V. C., Plenum Press, New York, 1991, pp. 95-104.
21. Sanford P. A., "Chitin and Chitosan," ed. by Skjak-braek G., Anthonsen T., Sanford P., Elsevier Applied Science, London, 1988 pp. 51-69.
22. Peniche C., Arguelles-Monal W., Peniche H., Acosta N., Macromolec. Biosci., 3, 511-520 (2003).
23. Gavini E., Hegge A. B., Rassu G., Sanna V., Testa C., Pirisino G., Karlsen J., Giunchedi P., Int. J. Pharm., 307, 9-15 (2006).
24. Bethea J. R., Castro M., Keane R. W., Lee T. T., Dietrich W. D., Yezierski R. P., J. Neurosci., 18, 3251-3260 (1998).
25. Rivlin A. S., Tator C. H., J. Neurosurg., 47, 577-581 (1977).
26. Freeman B. A., Crapo J. D., Lab. Invest., 47, 412-426 (1982).
27. Maxwell R. E., Long D. M., French L. A., J. Neurosurg., 34, 477-487 (1971).
28. Zhang X., Chen F., Ni J., Drug Deliv., 16, 280-288 (2009).
29. Vodna L., Bubenikova S., Bakos D., Macromol. Biosci., 7, 629-634 (2007).
30. De la Riva B., Nowak C., Sanchez E., Hernandez A., Schulz-Siegmund M., Pec M. K., Delgado A., Evora C., Eur. J. Pharm. Biopharm., 73, 50-58 (2009).
31. Wittayasuporn M., Rengpipat S., Palaga T., Asawanonda P., Anumansirikul N., Wanichwecharungruang S. P., J. Microencapsul., 27, 218-225 (2010).
32. Goycoolea F. M., Lollo G., Remunan-Lopez C., Quaglia F., Alonso M. J., Biomacromolecules, 10, 1736-1743 (2009).
33. Learoyd T. P., Burrows J. L., French E., Seville P. C., Int. J. Pharm., 372, 97-104 (2009).
34. Esmon C. T., FASEB J., 9, 946-955 (1995).
35. Esmon C. T., Blood, 95, 1113-1116 (2000).
36. Tator C. H., Fehlings M. G., J. Neurosurg., 75, 15-26 (1991).
37. Pan J. Z., Ni L., Sodhi A., Aguanno A., Young W., Hart R. P., J. Neurosci. Res., 68, 315-322 (2002).
38. Schnell L., Fearn S., Schwab M. E., Perry V. H., Anthony D. C., J. Neuropathol. Exp. Neurol., 58, 245-254 (1999).
39. Tuna M., Polat S., Erman T., Ildan F., Gocer A. I., Tuna N., Tamer L., Kaya M., Cetinalp E., J. Neurosurg., 95 (Suppl.), 64-73 (2001).
40. Taoka Y., Okajima K., Prog. Neurobiol., 56, 341-358 (1998).
41. Halliwell B., Gutteridge J. M. C., Trends Neurosci., 8, 22-26 (1985).
42. Bosel J., Gandor F., Harms C., Synowitz M., Harms U., Djoufack P. C., Megow D., Dirnagl U., Hortnagl H., Fink K. B., Endres M., J. Neurochem., 92, 1386-1398 (2005).
43. Lu D., Goussev A., Chen J., Pannu P., Li Y., Mahmood A., Chopp M., J. Neurotrauma, 21, 21-32 (2004).
44. Zacco A., Togo J., Spence K., Ellis A., Lloyd D., Furlong S., Piser T., J. Neurosci., 23, 11104-11111 (2003).
45. Clarke R. M., Lyons A., O'Connell F., Deighan B. F., Barry C. E., Anyakoha N. G., Nicolaou A., Lynch M. A., J. Biol. Chem., 283, 1808-1817 (2008).
46. Lee S. H., Kim Y. H., Kim Y. J., Yoon B. W., J. Neurol. Sci., 275, 64-68 (2008).